Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Heart disease is currently the leading cause of death of Americans
GHK-CU 50mg The 50mg option is commonly selected for: Smaller research projects Pilot studies Initial evaluations Short-term investigations GHK-CU 100mg The 100mg option is often preferred for: Larger research programs Extended study durations Ongoing laboratory investigations Researchers requiring additional material Both strengths contain the same quality-tested GHK-CU peptide and undergo identical quality control procedures
Your muscles need two things fast: carbs to reload glycogen and protein to rebuild tissue
Those comfortable with injection who prioritize efficacy over convenience should probably choose injectable BPC-157
*For Research Use Only* Last Updated: 2026-08-02 Our peptides are 3rd party tested and the results can be viewed before placing an order
Results at 68 weeks: 40.4% of CagriSema participants lost 25% or more of their body weight 91.9% lost at least 5% Blood pressure fell by 10.9 mmHg systolic on average About 40% of participants reduced or stopped blood pressure medications 87.7% of those with prediabetes at baseline achieved normal blood sugar Results were published in the New England Journal of Medicine and presented at the American Diabetes Associations 2026 Scientific Sessions
US$ 22.09
US$ 21.04
US$ 27.51
US$ 28.79
US$ 25.79
